| galantamine hydrobromide / Generic mfg. |
NCT00035204: A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease |
|
|
| Completed | 4 | 63 | US | galantamine | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Ortho-McNeil Neurologics, Inc. | Alzheimer Disease | | 05/03 | | |
NCT00181675: A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder |
|
|
| Completed | 4 | 40 | US | galantamine HBr | Massachusetts General Hospital | ADHD | | 09/03 | | |
NCT00234637: Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment |
|
|
| Completed | 4 | 204 | Europe | Rivastigmine, memantine | Novartis | Alzheimer's Disease | 06/05 | 06/05 | | |
NCT00423969: Galantamine Augmentation of Escitalopram for Treatment of Depression |
|
|
| Terminated | 4 | 20 | US | Galantamine, Escitalopram | Indiana University School of Medicine | Depression | | 09/05 | | |
NCT00216515: The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type |
|
|
| Completed | 4 | 102 | RoW | galantamine hydrobromide | Janssen Korea, Ltd., Korea | Alzheimer Disease | | 11/05 | | |
NCT00320736: Galantamine for Cognition in People With Schizophrenia |
|
|
| Completed | 4 | 20 | US | galantamine | North Suffolk Mental Health Association, Janssen Medical Affairs | Schizophrenia, Schizoaffective Disorder | | 05/06 | | |
NCT00195845: A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder |
|
|
| Completed | 4 | 30 | US | Galantamine, Placebos | Cambridge Health Alliance, Northwestern University | Bipolar Disorder | 09/06 | 02/07 | | |
NCT00176423: Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia |
|
|
| Completed | 4 | 117 | US | galantamine | University of Maryland, Baltimore, Stanley Medical Research Institute, Ortho-McNeil Neurologics, Inc. | Schizophrenia, Schizoaffective Disorder | 12/06 | 12/06 | | |
| Terminated | 4 | 21 | US | galantamine, Razadyne, Reminyl | Seattle Institute for Biomedical and Clinical Research | Schizophrenia, Psychotic Disorder | 06/07 | 06/07 | | |
NCT00626613: The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD) |
|
|
| Unknown status | 4 | | RoW | Risperdal,reminyl | Jinan Mental Hospital, Johnson & Johnson | Dementia, Alzheimer's Disease | | | | |
| Unknown status | 4 | 20 | Europe | Galantamine (Reminyl®), Placebo/Galantamine (Reminyl®) | Ludwig-Maximilians - University of Munich | Alzheimer's Disease | | 09/08 | | |
NCT01921972: The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease |
|
|
| Completed | 4 | 232 | Europe | Galantamine CR, Memantine, Placebo | Charite University, Berlin, Germany, German Federal Ministry of Education and Research | Alzheimer's Disease | 11/08 | 05/09 | | |
NCT01054976: The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease |
|
|
| Completed | 4 | 99 | RoW | Galantamine | Janssen Korea, Ltd., Korea | Alzheimer's Disease | 02/09 | 02/09 | | |
| Terminated | 4 | 1 | Europe | Galantamine | Janssen-Cilag, S.A. | Alzheimer Disease | 06/11 | 06/11 | | |
NCT01478633: Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil |
|
|
| Completed | 4 | 102 | Japan | Galantamine | Janssen Pharmaceutical K.K. | Alzheimer's Disease | 06/13 | 06/13 | | |
NCT01529619: Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors |
|
|
| Completed | 4 | 52 | Japan | Rivastigmine transdermal patch | Novartis Pharmaceuticals, Ono Pharmaceutical Co. Ltd | Alzheimer's Disease | 12/13 | 12/13 | | |
2008-006278-13: Motor function optimization in advanced Parkinson’s disease patients, combined with galantamine to prevent visual hallucinations. |
|
|
| Ongoing | 4 | 10 | Europe | Reminyl Retard, Sinemet 125 mg, Reminyl Retard, Sinemet 125 mg | UMCG | patients with advanced (>5 years) Parkinson\'s disease and visual hallucinations. | | | | |
2011-006011-62: The ACER-study - examining the effects of galantamine on gait. De ACER-studie - onderzoek naar de effecten van galantamine op het looppatroon. |
|
|
| Ongoing | 4 | 60 | Europe | galantamine, Reminyl Tablets 4mg, Reminyl Tablets 8mg, Reminyl Tablets 12mg, Reminyl Tablets 4mg, Reminyl Tablets 8mg, Reminyl Tablets 12mg | Slotervaart Hospital, Stichting Klinisch Wetenschappelijk Onderzoek Slotervaartziekenhuis (SKWOSZ) | Dementia of the Alzheimer type Dementie van het type Alzheimer | | | | |
2005-003245-14: Neuronale Korrelate von dysfunktionellen Aufmerksamkeitskomponenten bei Patienten mit Schizophrenie: cholinerge Rezeptorsysteme und pharmakologische Therapie |
|
|
| Ongoing | 4 | 15 | Europe | Reminyl, Galantamin, | Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Aachen | Patienten mit DSM-IVTR diagnostizierter Schizophrenie | | | | |
ENA1stepswitch, NCT02703636: NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients. |
|
|
| Completed | 4 | 118 | Japan | Rivastigmine Patch, rivastigmine | Novartis Pharmaceuticals | Mild to Moderate Alzheimer's Disease | 05/18 | 05/18 | | |
2017-000569-61: Comparison of therapeutic strategies with Cholinesterase Inhibitors: stop or still (SOS) trial |
|
|
| Not yet recruiting | 4 | 1205 | Europe | Donepezil, Galantamine, Rivastigmine, Donepezil, N06DA04, N06DA03, Coated tablet, Prolonged-release capsule, Capsule, ARICEPT, REMINYL, RIVASTIGMINE | CHU de Bordeaux, DGOS PHRC N 2016 | Alzheimer disease Maladie d'Alzheimer, Diagnosis of probable or possible AD, defined according to the NINCDS-ARDRA criteria cMild to moderate stage, defined by a MMSE score above 15 at the time of pré-inclusion Nouveau cas de Maladie d'AlzheimerDiagnostic de MA probable ou possible définie selon les critères NINCDS-ARDRA, Diseases [C] - Nervous System Diseases [C10] | | | | |
NCT03454646: Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL) |
|
|
| Not yet recruiting | 4 | 1205 | Europe | cholinesterase inhibitors (CI) (donepezil, galantamine or rivastigmine) | University Hospital, Bordeaux | Alzheimer Disease, Cholinesterase Inhibitors | 04/27 | 09/27 | | |
